You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Chapter title |
Certolizumab pegol: a PEGylated anti-tumour necrosis factor alpha biological agent
|
---|---|
Chapter number | 14 |
Book title |
PEGylated Protein Drugs: Basic Science and Clinical Applications
|
Published by |
Birkhäuser Basel, January 2009
|
DOI | 10.1007/978-3-7643-8679-5_14 |
Book ISBNs |
978-3-76-438678-8, 978-3-76-438679-5
|
Authors |
Andrew M. Nesbitt, Sue Stephens, Elliot K. Chartash |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 9 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 2 | 22% |
Professor | 1 | 11% |
Student > Doctoral Student | 1 | 11% |
Student > Master | 1 | 11% |
Student > Ph. D. Student | 1 | 11% |
Other | 0 | 0% |
Unknown | 3 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 2 | 22% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 11% |
Chemical Engineering | 1 | 11% |
Medicine and Dentistry | 1 | 11% |
Engineering | 1 | 11% |
Other | 0 | 0% |
Unknown | 3 | 33% |